118 related articles for article (PubMed ID: 28918099)
21. Cervical cancer screening: evidence behind the guidelines.
Lees BF; Erickson BK; Huh WK
Am J Obstet Gynecol; 2016 Apr; 214(4):438-443. PubMed ID: 26519782
[TBL] [Abstract][Full Text] [Related]
22. Diagnostic validity of human papillomavirus E6/E7 mRNA test in cervical cytological samples.
Liu TY; Xie R; Luo L; Reilly KH; He C; Lin YZ; Chen G; Zheng XW; Zhang LL; Wang HB
J Virol Methods; 2014 Feb; 196():120-5. PubMed ID: 24216236
[TBL] [Abstract][Full Text] [Related]
23. Evaluation of multiple primary and combination screening strategies in postmenopausal women for detection of cervical cancer in China.
Holt HK; Zhang L; Zhao FH; Hu SY; Zhao XL; Zhang X; Pan QJ; Zhang WH; Smith JS; Qiao YL
Int J Cancer; 2017 Feb; 140(3):544-554. PubMed ID: 27727464
[TBL] [Abstract][Full Text] [Related]
24. Approaches for triaging women who test positive for human papillomavirus in cervical cancer screening.
Tota JE; Bentley J; Blake J; Coutlée F; Duggan MA; Ferenczy A; Franco EL; Fung-Kee-Fung M; Gotlieb W; Mayrand MH; McLachlin M; Murphy J; Ogilvie G; Ratnam S
Prev Med; 2017 May; 98():15-20. PubMed ID: 28279257
[TBL] [Abstract][Full Text] [Related]
25. Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: preliminary results of a randomised controlled trial.
Moses E; Pedersen HN; Mitchell SM; Sekikubo M; Mwesigwa D; Singer J; Biryabarema C; Byamugisha JK; Money DM; Ogilvie GS
Trop Med Int Health; 2015 Oct; 20(10):1355-67. PubMed ID: 26031572
[TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus in cervical screening and vaccination.
Crosbie EJ; Kitchener HC
Clin Sci (Lond); 2006 May; 110(5):543-52. PubMed ID: 16597323
[TBL] [Abstract][Full Text] [Related]
27. Commentary on statement on human papillomavirus test utilization.
Cox JT; Moriarty AT; Castle PE
Arch Pathol Lab Med; 2009 Aug; 133(8):1192-4. PubMed ID: 19653706
[No Abstract] [Full Text] [Related]
28. Primary High-Risk Human Papillomavirus Testing for Cervical Cancer Screening in the United States: Is It Time?
Flanagan MB
Arch Pathol Lab Med; 2018 Jun; 142(6):688-692. PubMed ID: 29848034
[TBL] [Abstract][Full Text] [Related]
29. Secondary prevention of cervical cancer part 2: initial management of abnormal cervical cancer screening test.
Guido R
Clin Obstet Gynecol; 2014 Jun; 57(2):292-301. PubMed ID: 24785417
[TBL] [Abstract][Full Text] [Related]
30. The role of human papillomavirus testing in cervical cancer screening.
Morasse L; Davidov A; Castellanos MR
JAAPA; 2009 Nov; 22(11):20-3. PubMed ID: 19999172
[No Abstract] [Full Text] [Related]
31. Cervical Cancer Screening.
Guido R
Clin Obstet Gynecol; 2018 Mar; 61(1):40-51. PubMed ID: 29252924
[TBL] [Abstract][Full Text] [Related]
32. Exploring colposcopists' attitudes towards use of HPV testing as a primary screening tool for cervical cancer in British Columbia.
Regier DA; van der Hoek K; Ogilvie G; Smith L; Henwood E; Miller DM; McTaggart-Cowan H; Peacock SJ
J Obstet Gynaecol Can; 2013 Jul; 35(7):657-63. PubMed ID: 23876645
[TBL] [Abstract][Full Text] [Related]
33. Cervical cancer prevention: Human papillomavirus testing as primary screening.
Desai S; Zhu MJ; Lapidos-Salaiz I
Cancer; 2022 Mar; 128(5):939-943. PubMed ID: 34767263
[TBL] [Abstract][Full Text] [Related]
34. Practice Bulletin No. 157 Summary: Cervical Cancer Screening and Prevention.
Obstet Gynecol; 2016 Jan; 127(1):185-187. PubMed ID: 26695578
[TBL] [Abstract][Full Text] [Related]
35. Guidelines recommend less frequent screening interval for cervical cancer.
Twombly R
J Natl Cancer Inst; 2003 Mar; 95(6):424-5. PubMed ID: 12644532
[No Abstract] [Full Text] [Related]
36. The next generation of cervical cancer screening programs: Making the case for risk-based guidelines.
Perkins RB; Schiffman M; Guido RS
Curr Probl Cancer; 2018 Sep; 42(5):521-526. PubMed ID: 30146347
[No Abstract] [Full Text] [Related]
37. ACOG Practice Bulletin Number 131: Screening for cervical cancer.
Committee on Practice Bulletins—Gynecology
Obstet Gynecol; 2012 Nov; 120(5):1222-38. PubMed ID: 23090560
[TBL] [Abstract][Full Text] [Related]
38. Screening Guideline for Cervical Cancer Recommends Against Human Papillomavirus-Pap Cotesting.
Azvolinsky A
J Natl Cancer Inst; 2017 Dec; 109(12):. PubMed ID: 29155972
[No Abstract] [Full Text] [Related]
39. Statement on human papillomavirus DNA test utilization.
Solomon D; Papillo JL; Davey DD;
Arch Pathol Lab Med; 2009 Aug; 133(8):1276-7. PubMed ID: 19653725
[No Abstract] [Full Text] [Related]
40. Practice Bulletin No. 157: Cervical Cancer Screening and Prevention.
Obstet Gynecol; 2016 Jan; 127(1):e1-e20. PubMed ID: 26695583
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
